Company

INTEGRATED BIOPHARMA INC (INBP)

Standardized SEC financial data for INTEGRATED BIOPHARMA INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001016504 · OTC · Pharmaceutical Preparations.

Gross margin

10.2%

Operating margin

3.7%

Net margin

1.5%

Revenue growth (YoY)

8.0%

Return on equity

4.0%

ROIC

4.8%

Free cash flow

$1.9M

Debt / equity

0.00×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$52.8M	$63.6M	$56.2M	$50.7M	$50.3M	$54.4M
Cost of revenue	$46.0M	$54.1M	$49.7M	$46.6M	$46.4M	$48.8M
Gross profit	$6.7M	$9.5M	$6.6M	$4.1M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$402K	$210K	$331K	$1.3M	$1.7M	$3.6M
Inventory	$10.1M	$11.7M	$11.1M	$10.3M	$11.2M	$9.4M
Total current assets	$16.5M	$18.0M	$16.6M	$16.4M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$1.3M	$3.0M	$4.1M	$1.2M	$943K	$2.1M
Capital expenditures	$230K	$295K	$486K	$116K	$553K	$191K
Free cash flow	$1.1M	$2.8M	$3.6M	$1.1M

Get INBP data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INBP/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INBP/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View INBP filings on SEC EDGAR →